Jennifer Bealer - Nov 5, 2021 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
EVP, General Counsel
Signature
/s/ Jennifer Bealer
Stock symbol
PGNY
Transactions as of
Nov 5, 2021
Transactions value $
-$2,115,352
Form type
4
Date filed
11/9/2021, 07:57 PM
Previous filing
Oct 27, 2021
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Sale -$326K -5.04K -7.04% $64.66 66.6K Nov 5, 2021 Direct F1
transaction PGNY Common Stock Sale -$111K -1.7K -2.55% $65.10 64.9K Nov 5, 2021 Direct F1, F2, F3
transaction PGNY Common Stock Sale -$143K -2.16K -3.32% $66.28 62.7K Nov 5, 2021 Direct F1, F3, F4
transaction PGNY Common Stock Sale -$65.8K -981 -1.56% $67.09 61.8K Nov 5, 2021 Direct F1, F3, F5
transaction PGNY Common Stock Sale -$14.4K -211 -0.34% $68.06 61.5K Nov 5, 2021 Direct F1, F3, F6
transaction PGNY Common Stock Award $0 +30K +48.75% $0.00 91.5K Nov 8, 2021 Direct F7
transaction PGNY Common Stock Sale -$224K -3.46K -3.78% $64.61 88.1K Nov 8, 2021 Direct F1, F3, F8
transaction PGNY Common Stock Sale -$755K -11.5K -13.06% $65.66 76.6K Nov 8, 2021 Direct F1, F3, F9
transaction PGNY Common Stock Sale -$463K -6.96K -9.09% $66.55 69.6K Nov 8, 2021 Direct F1, F3, F10
transaction PGNY Common Stock Sale -$13.4K -200 -0.29% $67.17 69.4K Nov 8, 2021 Direct F1, F3, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Employee Stock Option (Right to Buy) Award $0 +115K $0.00 115K Nov 8, 2021 Common Stock 115K $66.66 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.47, inclusive.
F3 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (4), (5), (6), (8), (9), (10) and (11).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.55, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.60 to $67.51, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.32, inclusive.
F7 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.11 to $65.04, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.13 to $66.12, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $67.12, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.16 to $67.17, inclusive.
F12 One-fourth (1/4th) of the shares subject to the option will vest November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.